BLSM · BlossomHill Therapeutics, Inc.
Market Cap
$639.79M
Shares
29.08M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$21.51
Open$22.00
Day$20.68–22.39
Available close range$15.80–22.93
Avg vol available · 24d271K
Short int111K · 0.4% float · 1.0d
Short vol36%
DataAug 2026–Sep 2026
The closing range uses available history since Aug 7, 2026; less than a full year is stored.
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.4%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Limited
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
High
Market backdrop
VIX 17.8 · elevated
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
RSI (14)
68
neutral
52-week position
80%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Accumulating
Net +$25.2M over 90 days · 0% sells
Short interest
Falling
0.38% of float · ▼ -1.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
50
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
74%
annualized · 1-yr
Max drawdown
−8%
past year
ATR
6.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
RSI (14)
68
Neutral
52-week position
80%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Accumulating
Net +$25.2M over 90 days · 0% sells
Short interest
Falling
0.38% of float · ▼ -1.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its available closing range
Range low $16
Now $22 · 80%
Range high $23
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BLSM
this stock
BlossomHill Therapeutics, Inc.
|
$639.79M | — | — | — | 0.4% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.08B | +13.5% | +46.2% | 30.4 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.15B | +2.8% | +20.8% | 20.0 | 2.5% |
|
ARGX
Argenx SE
|
$62.33B | +17.0% | — | — | 2.0% |
|
CSLLY
Csl Ltd
|
$58.10B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BLSM | +11.0% | +32.5% | — | +17.5% | — |
| SPY | -1.0% | -1.9% | +14.9% | -1.2% | +11.1% |
| vs SPY | +12.0% | +34.4% | — | +18.7% | — |